Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-943-4 | CAS number: 598-63-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- The Deposition and Removal of Lead in the Soft Tissues (Liver, Kidneys, and Spleen)
- Author:
- Fairhall LT & Miller JW
- Year:
- 1 941
- Bibliographic source:
- Public Health Reports Vol. 56 No. 33 (Reprint No. 2304), pages 1641-1650
Materials and methods
- Objective of study:
- distribution
- Principles of method if other than guideline:
- Frequently the metal content of a given tissue is related to its pathology and because of the probable variable shift in amount of the deposited material within a relatively short time the following experiments were undertaken to verify this and to find out the extent to which this shift occurred with lead during a reasonable interval. As a change in the soft tissue content of lead had been noted in similar groups of animals killed within less than a week after lead ingestion had ceased, it was felt that a 14-day rest period would be sufficient to indicate a definite difference.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Lead carbonate
- EC Number:
- 209-943-4
- EC Name:
- Lead carbonate
- Cas Number:
- 598-63-0
- Molecular formula:
- CH2O3.Pb
- IUPAC Name:
- λ²-lead(2+) carbonate
Constituent 1
- Radiolabelling:
- not specified
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Duration and frequency of treatment / exposure:
- 66 (52 +14) days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
15 mg / day during 52 days
- Control animals:
- not specified
Results and discussion
Main ADME results
- Type:
- distribution
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- When lead is absorbed into the body there occurs a general flooding of all the tissues by the lead stream, which the system as a whole tends to correct either by increased excretion or by deposition of the lead in the bone tissue.
- Details on distribution in tissues:
- The average content in the livers of the former group was 0.020 mg. per liver, or a concentration of 0.032 mg. per 10 gm. of tissue.
The average content in the livers of the group following the rest period was 0.011 mg., or 0.016 mg. per 10 gm. of liver.
Similarly, the average content in the kidneys of the first group was 0.055 mg., or 0.427 mg. per 10 gm. of kidney, while in t.he second group the average lead content was 0.031 mg. per kidney, or 0.217 mg. per 10 gm. of tissue.
The average lead content in the spleens of the first group was 0.003 mg., as compared with 0.004 mg. in the second group, but, as stated previously, these quantities are so low that comparisons are scarcely reliable.
In contrast, with the lead content of the softer tissues, the bones show a slight increase in lead content in the second group, although these imals received no more lead than the first group and furthermore had an opportunity of excreting part of the lead during the 14-day rest period.
The average amount of lead present in the bones of the animals of the first group was 0.93 mg. per animal, or 3.30 mg. per 10 gm. of bone tissue, while that of the second group was 1.14 mg. per animal, or 3.65 mg. per 10 gm. of bone tissue.
Metabolite characterisation studies
- Metabolites identified:
- not specified
Any other information on results incl. tables
It has been shown that lead deposited in the softer tissues in rats fed approximately 15 mg. of lead carbonate a day for 6 weeks is transitory in nature and may be diminished by 50 percent within 2 weeks merely by restoration to a normal diet. Coincidently there is a slight rise in the lead content of the bone tissue.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
In the conditions of the study, lead carbonate did not show a high bioaccumulation in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.